Search results
Blincyto Picks Up New BCP-ALL Indication
Medscape· 6 days agoThe agent is the first BiTE approved for consolidation regardless of MRD status.
To Your Good Health: Iron still isn't being absorbed properly amid infusions
The Marshall News Messenger· 3 days agoROACH: I was prescribed iron for a low iron level due to “microcytic anemia.” How do I know if this...
WanaBana recall update: FDA sends warning letter to Dollar Tree over lead-contaminated cinnamon...
Yahoo Life· 6 days agoAlthough some children will develop stomach pain, headaches, vomiting and anemia shortly after...
My daughter was losing weight. Nothing prepared me for Her diagnosis
Newsweek· 6 days agoMy 10-year-old daughter, Averi, went from being a healthy, active child to fighting for her life in...
US FDA approves Roche's drug for a chronic blood disorder (June 21)
Reuters via Yahoo News· 3 days agoThe U.S. Food and Drug Administration on Thursday approved Roche's drug for a chronic blood...
Surprising Science-Backed Benefits of Green Tea
Prevention· 3 days agoFrom your head to your stomach, green tea health benefits are vast. While all teas are high in antioxidants, green teas (including matcha, jasmine, and...
Coping with cancer-related fatigue
Medical Xpress· 6 days agoPeople can experience cancer-related fatigue before, during and after treatments. This is different from the typical tiredness. Cancer-related fatigue...
My Wife Died Fighting for Her Life After Giving Birth to Our Twins. How I'm Keeping Her Memory Alive...
People Magazine· 2 days agoRabbi Jenn Weinstein, 46, and her wife Andrea Termotto welcomed identical twin daughters on May 31....
EHA 2024: Monoclonal antibodies continue to dominate multiple myeloma treatments
Pharmaceutical Technology via Yahoo Finance· 3 days agoThe 12-month OS was 75% for all patients and 100% for those with CR. As a result, not all patients,...
Multidrug Regimen Could Change Treatment Landscape for Relapsed/Refractory DLBCL
MedPage Today· 5 days agoHigh-rate of durable responses with ViPOR sparks talk of supplanting CAR-T in second line